KYMPRAME Trademark

Trademark Overview


On Tuesday, May 31, 2022, a trademark application was filed for KYMPRAME with the United States Patent and Trademark Office. The USPTO has given the KYMPRAME trademark a serial number of 97435341. The federal status of this trademark filing is WITHDRAWN BEFORE PUBLICATION as of Wednesday, November 29, 2023. This trademark is owned by Immunocore Limited. The KYMPRAME trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of tumorous diseases; pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of cancer; pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of melanoma, lung cancer, ovarian cancer, uterine cancer, breast cancer, neurothelial cancer, endometrial cancer, oesophageal cancer, sarcoma, haematological cancers, acute myeloid leukemia, chronic myeloid leukemia, Hodgkin's lymphoma, and head and neck cancers
kymprame

General Information


Serial Number97435341
Word MarkKYMPRAME
Filing DateTuesday, May 31, 2022
Status692 - WITHDRAWN BEFORE PUBLICATION
Status DateWednesday, November 29, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Name/Portrait Description and/or Consent StatementThe name(s), portrait(s), and/or signature(s) shown in the mark does not identify a particular living individual.
Goods and ServicesPharmaceutical preparations, biological preparations and bispecific reagents for the treatment of tumorous diseases; pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of cancer; pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of melanoma, lung cancer, ovarian cancer, uterine cancer, breast cancer, neurothelial cancer, endometrial cancer, oesophageal cancer, sarcoma, haematological cancers, acute myeloid leukemia, chronic myeloid leukemia, Hodgkin's lymphoma, and head and neck cancers

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 7, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameImmunocore Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAbingdon, Oxfordshire OX144RY
GB

Trademark Events


Event DateEvent Description
Wednesday, November 29, 2023ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, November 16, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 14, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 14, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 14, 2023ASSIGNED TO LIE
Friday, June 9, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 23, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 23, 2023NON-FINAL ACTION E-MAILED
Thursday, March 23, 2023NON-FINAL ACTION WRITTEN
Thursday, March 16, 2023ASSIGNED TO EXAMINER
Wednesday, December 28, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, June 7, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 3, 2022NEW APPLICATION ENTERED